Alex Corbacho
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Highest-materiality recent filing
Suja Life refinances debt: spread cut to SOFR +1.75%-2.25%; 2026 interest expense seen at $18.0M
A&R Credit Agreement signed Aug 20, 2026 with JPMorgan Chase Bank, N.A. as admin agent; restates Aug 23, 2021 agreement.
Suja Life Q2 net sales up 11.6% to $83.9M; net loss widens to $27.8M on IPO costs
Net sales $83.9M, +11.6% YoY; gross margin 46.7% vs 47.4%.
Suja Life Q1 net sales $107.1M (+22.5% YoY); Adj. EBITDA $25.0M (+66.3%)
Net sales of $107.1M, up 22.5% YoY from $87.4M.
Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026
Sold 8,888,889 shares of Class A common stock at $21.00 per share; underwriters have 30-day option for 1,333,333 additional shares.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck were appointed to the Company’s board of directors.
Max materiality 0.90 · Median 0.75 · Most common event earnings